This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Title: Xixi Feng: Innovator in Psychiatric Disorder Treatments
Introduction
Xixi Feng is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of psychiatric disorder treatments, holding 2 patents that focus on innovative compounds for therapeutic applications.
Latest Patents
Her latest patents include "Selective FKBP51 ligands for treatment of psychiatric disorders." This invention relates to compounds that possess a selective FKBP51 ligand scaffold, along with their pharmaceutically acceptable salts and compositions. These compounds are designed for the prophylaxis and treatment of psychiatric disorders and neurodegenerative diseases. The second patent also focuses on similar compounds, emphasizing their potential in addressing various psychiatric conditions.
Career Highlights
Xixi Feng has worked with esteemed institutions such as the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. and the Technical University of Darmstadt. Her work in these organizations has allowed her to advance her research and contribute to the scientific community.
Collaborations
Some of her notable coworkers include Felix Hausch and Andreas Bracher, who have collaborated with her on various projects related to her research.
Conclusion
Xixi Feng's innovative work in developing selective FKBP51 ligands showcases her dedication to improving treatments for psychiatric disorders. Her contributions are paving the way for advancements in mental health therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile